P K Morrish
Affiliation: Cardiff University
- Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PETP K Morrish
MRC Cyclotron Unit Hammersmith Hospital, London, UK
J Neurol Neurosurg Psychiatry 64:314-9. 1998....
- Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's diseaseK Ito
MRC Cyclotron Unit, Hammersmith Hospital, London, UK
J Neurol Neurosurg Psychiatry 66:754-8. 1999..To apply statistical parametric mapping to 18F-dopa PET data sets, to examine the regional distribution of changes in dopaminergic metabolism in early asymmetric Parkinson's disease...
- Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET studyJ S Rakshi
MRC Cyclotron Unit, Hammersmith Hospital, The Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK
Brain 122:1637-50. 1999..This suggests, therefore, that Parkinson's disease is a monoaminergic neurodegenerative disorder...
- A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET studyJ S Rakshi
MRC Clinical Sciences Centre Imperial College School of Medicine, Hammersmith Hospital, London, UK
J Neural Transm 109:1433-43. 2002..To study the relative rates of progression of early Parkinson's disease (PD) in patients started on a dopamine agonist, ropinirole, or L-dopa...